LINC00092 and ovarian carcinoma: A previous study shown that LINC00092, activated by CXCL14-rich CAFs, drives ovarian cancer metastasis by modulating glycolysis via PFKFB2 interaction, underscoring a vital metabolic feedback loop between CAFs and cancer cell advancement [38].